# OnCo record cinrebafusp-alfa (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/cinrebafusp-alfa/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "cinrebafusp-alfa" ;
  schema:name "Cinrebafusp alfa"@en ;
  schema:alternateName "Cinrebafusp alfa (PRS-343)"@en ;
  schema:description "Cinrebafusp alfa is an experimental fusion protein from Pieris Pharmaceuticals in phase 2 trials for gastric & gastro-oesophageal junction cancer, aimed at HER2."@en ;
  schema:url <https://onco.cc/drugs/cinrebafusp-alfa/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=PRS-343> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "fusion protein" ;
  onco:cancers <https://onco.cc/cancers/gastric/> ;
  onco:targets <https://onco.cc/targets/her2/>, <https://onco.cc/targets/cd137/> ;
  onco:companies <https://onco.cc/companies/pieris-pharmaceuticals/> ;
  onco:trials <https://onco.cc/trials/nct05190445/> .
